Equities

Onconetix Inc

Onconetix Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.76
  • Today's Change-0.22 / -11.11%
  • Shares traded80.98k
  • 1 Year change-86.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Onconetix Inc fell by 21.20m. Cash Flow from Financing totalled 1.04m or 1,770.24% of revenues. In addition the company used 13.58m for operations while cash used for investing totalled 8.65m.
Cash flow per share-104.11
Price/Cash flow per share--
Book value per share50.92
Tangible book value per share-50.85
More ▼

Balance sheet in USDView more

Onconetix Inc has a Debt to Total Capital ratio of 29.84%, a lower figure than the previous year's 34.70%.
Current ratio0.0988
Quick ratio0.091
Total debt/total equity0.5312
Total debt/total capital0.2984
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.